MedTrace Logo

Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients

NCT00394485 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2009-12-17

No results posted yet for this study

Summary

Study compares the efficacy and safety of tiotropium + a beta agonist (procaterol) vs. tiotropium alone among patients with moderate chronic obstructive pulmonary disease

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Procaterol

DRUG

Tiotropium

Sponsors & Collaborators

  • Otsuka Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Otsuka Pharmaceutical, Inc., Philippines

    lead INDUSTRY

Principal Investigators

  • Abundio A Balgos, MD · University of the Philippines College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Completion
2008-04-30

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00394485 on ClinicalTrials.gov